Drugs / Gardasil 9 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06786429 | Aug 2026 → Sep 2031 expected | cervical cancer, gallstones, hepatitis B virus infection, human papilloma virus infection +2 | Eunice Dube | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gardasil 9 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06786429 ↗ |
| Modality | Vaccine | “Biological: Gardasil 9 vaccine” NCT06786429 ↗ |